Siddiqui WA, Schnell JV, Geiman QM, 1972. A model in vitro system to test susceptibility of human malaria parasites to antimalarial drugs. Am J Trop Med Hyg 21 :392–399.
Geiman QM, Meagher MJ, 1967. Susceptibility of a New World monkey to Plasmodium falciparum.Nature 215 :437–439.
Collins WE, Anders RF, Ruebush TK II, Kemp DJ, Woodrow GC, Campbell GH,Brown GV, Irving DO, Gross N, Filipski VK, Coppel RL, Broderson JR, Thomas LM, Pye D, Skinner JC, Wilson C, Stanfill PS, Procell PM, 1991. Immunization of owl monkeys with ring-infected erythrocyte surface antigen of Plasmodium falciparum.Am J Trop Med Hyg 44 :34–41.
Ruebush TK II, Campbell GH, Moreno AO, Patarroyo ME, Collins WE, 1990. Immunization of owl monkeys with a combination of Plasmodium falciparum asexual blood-stage synthetic peptide antigens. Am J Trop Med Hyg 43 :355–366.
Sharma P, Ruebush TK II, Campbell GH, Richman SJ, Wilkins PM, Broderson JR, Ardeshir F, Gross M, Silverman C, Skinner JC, Filipski V, Wilson C, Roberts JM, Ma NF-S, Stanfill PS, Reese RT, Collins WE, 1992. Immunogenicity and efficacy trials in Aotus nancymai monkeys with model compounds representing parts of a 75-kD merozoite surface antigen of Plasmodium falciparum.Am J Trop Med Hyg 46 :691–707.
Berzins K, Adams S, Broderson JR, Chizzolini C, Hansson M, Lovgren K, Millet P, Morris CL, Perlmann H, Perlmann P, Sjolander A, Stahl S, Sullivan JS, Troye-Blomberg M, Collins WE, 1995. Immunogenicity in Aotus monkeys of ISCOM formulated repeat sequences from the Plasmodium falciparum asexual blood stage antigen Pf155/RESA. Vaccine Res 4 :121–133.
Collins WE, Walduck A, Sullivan JS, Andrews K, Stowers A, Morris CL, Jennings V, Yang C, Kendall J, Lin Q, MArtin LB, Diggs C, Saul A, 2000. Efficacy of vaccines containing rhoptry-associated proteins RAP1 and RAP2 of Plasmodium falciparum in Saimiri boliviensis monkeys. Am J Trop Med Hyg 62 :466–479.
Kumar S, Collins WE, Egan A, Yadava A, Girrard O, Blackman M, Guevara Patino JA, Diggs C, Kaslow D, 2000. Immunogenicity and efficacy in Aotus monkeys of four recombinant Plasmodium falciparum vaccines in multiple adjuvant formulations based on the 19-kD C-terminus of the merozoite surface protein 1 (MSP-1). Infect Immun 68 :2215–2223.
Collins WE, Galland GG, Sullivan JS, Morris CL, 1994. Selection of different strains of Plasmodium falciparum for testing blood-stage vaccines in Aotus nancymai monkeys. Am J Trop Med Hyg 51 :224–232.
Earle WC, Perez M, 1932. Enumeration of parasites in blood of malarial patients. J Lab Clin Med 17 :1124–1130.
Snounou G, Viriyakosol S, Jarra W, Thaithong S, Brown KN, 1993. Identification of the four human malaria parasite species in field samples by the polymerase chain reaction and detection of a high prevalence of mixed infections. Mol Biochem Parasitol 58 :283–292.
Past two years | Past Year | Past 30 Days | |
---|---|---|---|
Abstract Views | 1377 | 1319 | 37 |
Full Text Views | 271 | 12 | 0 |
PDF Downloads | 64 | 9 | 0 |
A strain of Plasmodium falciparum from Ghana was adapted to Aotus lemurinus griseimembra, A. nancymai, and A. vociferans monkeys. Gametocytes in splenectomized A. nancymai were infective to Anopheles freeborni mosquitoes. Sporozoite transmission was accomplished in two splenectomized A. nancymai with prepatent periods of 22 and 25 days. The Ghana III/CDC strain of P. falciparum is susceptible to treatment with chloroquine and mefloquine.
Siddiqui WA, Schnell JV, Geiman QM, 1972. A model in vitro system to test susceptibility of human malaria parasites to antimalarial drugs. Am J Trop Med Hyg 21 :392–399.
Geiman QM, Meagher MJ, 1967. Susceptibility of a New World monkey to Plasmodium falciparum.Nature 215 :437–439.
Collins WE, Anders RF, Ruebush TK II, Kemp DJ, Woodrow GC, Campbell GH,Brown GV, Irving DO, Gross N, Filipski VK, Coppel RL, Broderson JR, Thomas LM, Pye D, Skinner JC, Wilson C, Stanfill PS, Procell PM, 1991. Immunization of owl monkeys with ring-infected erythrocyte surface antigen of Plasmodium falciparum.Am J Trop Med Hyg 44 :34–41.
Ruebush TK II, Campbell GH, Moreno AO, Patarroyo ME, Collins WE, 1990. Immunization of owl monkeys with a combination of Plasmodium falciparum asexual blood-stage synthetic peptide antigens. Am J Trop Med Hyg 43 :355–366.
Sharma P, Ruebush TK II, Campbell GH, Richman SJ, Wilkins PM, Broderson JR, Ardeshir F, Gross M, Silverman C, Skinner JC, Filipski V, Wilson C, Roberts JM, Ma NF-S, Stanfill PS, Reese RT, Collins WE, 1992. Immunogenicity and efficacy trials in Aotus nancymai monkeys with model compounds representing parts of a 75-kD merozoite surface antigen of Plasmodium falciparum.Am J Trop Med Hyg 46 :691–707.
Berzins K, Adams S, Broderson JR, Chizzolini C, Hansson M, Lovgren K, Millet P, Morris CL, Perlmann H, Perlmann P, Sjolander A, Stahl S, Sullivan JS, Troye-Blomberg M, Collins WE, 1995. Immunogenicity in Aotus monkeys of ISCOM formulated repeat sequences from the Plasmodium falciparum asexual blood stage antigen Pf155/RESA. Vaccine Res 4 :121–133.
Collins WE, Walduck A, Sullivan JS, Andrews K, Stowers A, Morris CL, Jennings V, Yang C, Kendall J, Lin Q, MArtin LB, Diggs C, Saul A, 2000. Efficacy of vaccines containing rhoptry-associated proteins RAP1 and RAP2 of Plasmodium falciparum in Saimiri boliviensis monkeys. Am J Trop Med Hyg 62 :466–479.
Kumar S, Collins WE, Egan A, Yadava A, Girrard O, Blackman M, Guevara Patino JA, Diggs C, Kaslow D, 2000. Immunogenicity and efficacy in Aotus monkeys of four recombinant Plasmodium falciparum vaccines in multiple adjuvant formulations based on the 19-kD C-terminus of the merozoite surface protein 1 (MSP-1). Infect Immun 68 :2215–2223.
Collins WE, Galland GG, Sullivan JS, Morris CL, 1994. Selection of different strains of Plasmodium falciparum for testing blood-stage vaccines in Aotus nancymai monkeys. Am J Trop Med Hyg 51 :224–232.
Earle WC, Perez M, 1932. Enumeration of parasites in blood of malarial patients. J Lab Clin Med 17 :1124–1130.
Snounou G, Viriyakosol S, Jarra W, Thaithong S, Brown KN, 1993. Identification of the four human malaria parasite species in field samples by the polymerase chain reaction and detection of a high prevalence of mixed infections. Mol Biochem Parasitol 58 :283–292.
Past two years | Past Year | Past 30 Days | |
---|---|---|---|
Abstract Views | 1377 | 1319 | 37 |
Full Text Views | 271 | 12 | 0 |
PDF Downloads | 64 | 9 | 0 |